DIAGNOSTIC AND MANAGEMENT OVERVIEW OF COVID-19 ELDERLY PATIENTS AT ROYAL PRIMA HOSPITAL MEDAN
Abstract
Latar Belakang: Coronavirus Disease-2019 (COVID-19) merupakan infeksi yang disebabkan oleh coronavirus 2 sindrom pernapasan akut atau Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2). Gejala yang sering dijumpai adalah demam, batuk, hilang penciuman dan sesak nafas. Pemeriksaan yang dapat dilakukan adalah PCR, foto thorax, CT-Scan dan D-Dimer. Pada penderita Covid-19 dapat diperberat jika pasien berumur lansia (≥ 60 tahun). Tujuan: Untuk mengetahui gambaran diagnostic dan penatalaksanaan Covid-19 pada pasien lansia di RSU Royal Prima Medan. Metode Penelitian: Penelitian ini menggunakan metode kuantitatif yang bersifat deskriptif retrospektif. Penelitian ini menggunakan data sekunder, yaitu rekam medis Covid-19 pada pasien lansia di RSU Royal Prima Medan. Jenis teknik pengambilan sampel dalam penelitian adalah Purposive Sampling dengan kriteria pasien lansia yang berusia ≥60 tahun, pasien Covid-19 lansia dengan data lengkap, pasien Covid-19 lansia yang dinyatakan sembuh dengan jumlah 100 pasien. Hasil: Berdasarkan data rekam medik didapatkan usia pada lansia yang paling banyak terkena Covid-19 dimortalitas usia 71-75 tahun, dan dimana didominasi oleh laki-laki. Gejala klinis yang paling sering didapatkan yaitu Demam + Batuk + Sesak Napas + Lemas, dan Pcr + Foto Thoraks + D-Dimer sebagai pemeriksaan penunjang yang paling sering dilaksanakan oleh pasien. Penatalaksanaan yang paling sering diberikan yaitu Antibiotik (Levofloxacin) + Antivirus (Remdesivir) + Antipiretik (Paracetamol) + Vitamin. Kesimpulan: Pada hasil penelitian didapatkan bahwa terdapat 100 pasien lansia yang terkena Covid-19 dengan gejala dominan: demam, batuk, sesak napas dan lemas. Selanjutnya didapatkan penatalaksanaan paling sering diberikan adalah Levofloxacin, Remdesivir, Paracetamol dan Vitamin.
Kata kunci: Coronavirus Disease-2019; Covid-19; Lansia; Diagnostik; Penatalaksanaan.
Abstract
Background: Coronavirus Disease-2019 (COVID-19) is an infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2). The most common symptoms are fever, cough, loss of smell and shortness of breath. Examinations that can be done are PCR, chest X-ray, CT-Scan and D-Dimer. In patients with Covid-19, it can be aggravated if the patient is elderly (≥ 60 years). Objective: To determine the diagnostic and management of covid-19 in elderly patients at RSU Royal Prima Medan in October-December 2020. Research Methods: This study used a quantitative method with a retrospective descriptive study. This study uses secondary data, medical records of Covid-19 in elderly patients at RSU Royal Prima Medan. The type of sampling technique in this study is Purposive Sampling with criteria for elderly patients aged ≥60 years, Covid-19 patients elderly with complete data, elderly patients who were declared cured with a total of 100 patients. Results: Based on medical record data, it was found that the age of the elderly who were most affected by Covid-19 mortality was aged 71-75 years, and which was dominated by men. The most common clinical symptoms are Fever + Cough + Shortness of Breath + Weakness, and Pcr + Chest X-ray + D-Dimer as the most frequent investigation carried out by patients. The most frequently given treatment is antibiotics (Levofloxacin) + antivirus (Remdesivir) + antipyretics (Paracetamol) + vitamin. Conclusion: In the results of this study, it was found that there were 100 elderly patients affected by Covid-19 with dominant symptoms: fever, cough, shortness of breath and weakness. Furthermore, the treatment most often given was Levofloxacin, Remdesivir, Paracetamol and Vitamins.
Keywords: Coronavirus Disease-19; Covid-19; Elderly; Diagnostic; Treatment.
Full Text:
PDFReferences
Zein A. Pendeteksian VIirus Corona Dalam Gambar X-Ray Menggunakan Algoritma Artifical Intelligence Dengan Deep Learning Python. J Teknol Inf ESIT. 2020;XV(01):19–23.
Yuniarti Tejasari, m dan purbaningsih, Wida L. Bunga Rampai Artikel Penyakit Virus Korona ( COVID-19 ) Editor : Titik Respati. Kopidpedia. 2020;24–35.
WHO. COVID-19 [Internet]. 2021. Available from: https://covid19.who.int/
kemkes. Kementerian Kesehatan Republik Indonesia [Internet]. 2020. Available from: kemkes.go.id
Umakanthan S, Sahu P, Ranade A V., Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID 19). Postgrad Med J. 2020;96(1142):753–8.
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. J Penyakit Dalam Indones [Internet]. 2020 Apr 1;7(1):45. Available from: http://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/415
PERKI. Panduan Diagnosis dan Tatalaksana Penyakit Kardiovaskular pada Pandemi Covid-19. Perhimpun Dr Spes Kardiovask Indones [Internet]. 2020; Available from: https://inaheart.org/Wpcontent/Uploads/2021/07/Finalpanduan_Diagnosis_Dan_Tatalaksana_Penyakit_Kardiovaskular_Pada_Pandemi_Covid-19.Pdf
Satuan Tugas Penanganan COVID-19. Peta sebaran 22 November 2020 [Internet]. 2020. Available from: https:/covid19.go.id/peta-sebaran
Ahmad F. Gambaran Kondisi Lansia Penderita Covid-19 Dengan Penyakit Diabetes Melitus Dan Hipertensi. Univ Muhammadiyah Surakarta [Internet]. 2021; Available from: http://eprints.ums.ac.id/89249/1/Naskah publikasi.Pdf
Kemenkes RI. pedoman pencegahan dan pengendalian COVID-19. 2020.
Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, et al. Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano [Internet]. 2020 Apr 28;14(4):3822–35. Available from: https://pubs.acs.org/doi/10.1021/acsnano.0c02624
PDPI. Pneumonia Covid-19 Diagnosis & Penatalaksanaan di Indonesia. Perhimpun Dr Paru Indonesia Jakarta [Internet]. 2020; Available from: https://klikpdpi.com/Bukupdpi/Wp-Content/Uploads/2020/04/Buku-Pneumonia-Covid-19-Pdpi-2020.Pdf
DOI: https://doi.org/10.35971/jjhsr.v4i1.12207
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Jambura Journal of Health Sciences and Research is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
</p